Hilltop National Bank Makes New Investment in Danaher Corporation $DHR

Key Points

• Hilltop National Bank has acquired a new stake in Danaher Corporation, purchasing 1,617 shares valued at approximately $319,000 in the second quarter.
• Institutional investors hold a significant majority of Danaher's stock, owning 79.05% of the company.
• Danaher recently announced a quarterly dividend of $0.32 per share, which will be paid on October 31st, representing an annual yield of 0.6%.

Hilltop National Bank acquired a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 1,617 shares of the conglomerate's stock, valued at approximately $319,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in DHR. MGO One Seven LLC raised its stake in shares of Danaher by 485.7% during the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock valued at $5,145,000 after acquiring an additional 20,813 shares during the last quarter. Chicago Capital LLC increased its holdings in Danaher by 11.6% during the 2nd quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate's stock valued at $2,634,000 after purchasing an additional 1,391 shares during the period. UniSuper Management Pty Ltd raised its position in Danaher by 1.6% during the 1st quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate's stock valued at $34,954,000 after purchasing an additional 2,667 shares during the last quarter. Asahi Life Asset Management CO. LTD. purchased a new stake in Danaher in the 1st quarter worth approximately $539,000. Finally, Horizon Financial Services LLC grew its position in shares of Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after buying an additional 8,160 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on DHR shares. Robert W. Baird raised their price target on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a research report on Tuesday, September 2nd. Bank of America cut their target price on shares of Danaher from $230.00 to $220.00 and set a "buy" rating on the stock in a research note on Monday, September 22nd. Evercore ISI decreased their price target on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Finally, UBS Group cut their price objective on Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and a consensus target price of $245.91.

Insider Buying and Selling

In other news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 11.10% of the company's stock.

Danaher Trading Up 2.2%

Shares of NYSE DHR opened at $215.05 on Friday. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.41. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm has a 50-day moving average of $200.19 and a 200 day moving average of $197.42. The stock has a market cap of $153.98 billion, a P/E ratio of 45.75, a price-to-earnings-growth ratio of 3.00 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter last year, the firm earned $1.72 earnings per share. The business's revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher's payout ratio is presently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.